The Losartan Intervention For Endpoint Reduction (LIFE) in hypertension study: Rationale, design, and methods
Gespeichert in:
| Veröffentlicht in: | American journal of hypertension 1997-07, Vol.10 (7), p.705-713 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 713 |
|---|---|
| container_issue | 7 |
| container_start_page | 705 |
| container_title | American journal of hypertension |
| container_volume | 10 |
| creator | DAHLÖF, B DEVEREUX, R LINDHOLM, L. H NIEMINEN, M. S OMVIK, P OPARIL, S WEDEL, H DE FAIRE, U FYHRQUIST, F HEDNER, T IBSEN, H JULIUS, S KJELDSEN, S KRISTIANSON, K LEDERBALLE-PEDERSEN, O |
| description | |
| doi_str_mv | 10.1016/S0895-7061(97)00054-X |
| format | Article |
| fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_2187703</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2187703</sourcerecordid><originalsourceid>FETCH-LOGICAL-p182t-d0192bb1882e64b13fc0327863dd1ad8e6e8a0d10bf2b9cdf1c11faf7055f4f93</originalsourceid><addsrcrecordid>eNo9kM1KAzEURoMoWKuPIGThokJH752fTOJOSquFAaFWcFcykxs70maGJBX69rYqrj44HM7iY-wa4Q4Bxf0rSFUkJQgcqfIWAIo8eT9hA5SlSlBBccoG_8o5uwjh8yDlQuCAbZdr4lUXtI_a8bmL5L_IxbZzfNZ5PnWm71oX-YLMrvnBo2o-m97y1vH1vicfyYUjDnFn9g98oY-S3tCYGwrthxtz7QzfUlx3JlyyM6s3ga7-dsjeZtPl5DmpXp7mk8cq6VGmMTGAKq1rlDIlkdeY2QaytJQiMwa1kSRIajAItU1r1RiLDaLVtoSisLlV2ZDd_HZ7HRq9sV67pg2r3rdb7fer9PBMCVn2DRnLXVU</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Losartan Intervention For Endpoint Reduction (LIFE) in hypertension study: Rationale, design, and methods</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>DAHLÖF, B ; DEVEREUX, R ; LINDHOLM, L. H ; NIEMINEN, M. S ; OMVIK, P ; OPARIL, S ; WEDEL, H ; DE FAIRE, U ; FYHRQUIST, F ; HEDNER, T ; IBSEN, H ; JULIUS, S ; KJELDSEN, S ; KRISTIANSON, K ; LEDERBALLE-PEDERSEN, O</creator><creatorcontrib>DAHLÖF, B ; DEVEREUX, R ; LINDHOLM, L. H ; NIEMINEN, M. S ; OMVIK, P ; OPARIL, S ; WEDEL, H ; DE FAIRE, U ; FYHRQUIST, F ; HEDNER, T ; IBSEN, H ; JULIUS, S ; KJELDSEN, S ; KRISTIANSON, K ; LEDERBALLE-PEDERSEN, O</creatorcontrib><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1879-1905</identifier><identifier>DOI: 10.1016/S0895-7061(97)00054-X</identifier><language>eng</language><publisher>New York, NY: Elsevier Science</publisher><subject>Antihypertensive agents ; Biological and medical sciences ; Cardiovascular system ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>American journal of hypertension, 1997-07, Vol.10 (7), p.705-713</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2187703$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>DAHLÖF, B</creatorcontrib><creatorcontrib>DEVEREUX, R</creatorcontrib><creatorcontrib>LINDHOLM, L. H</creatorcontrib><creatorcontrib>NIEMINEN, M. S</creatorcontrib><creatorcontrib>OMVIK, P</creatorcontrib><creatorcontrib>OPARIL, S</creatorcontrib><creatorcontrib>WEDEL, H</creatorcontrib><creatorcontrib>DE FAIRE, U</creatorcontrib><creatorcontrib>FYHRQUIST, F</creatorcontrib><creatorcontrib>HEDNER, T</creatorcontrib><creatorcontrib>IBSEN, H</creatorcontrib><creatorcontrib>JULIUS, S</creatorcontrib><creatorcontrib>KJELDSEN, S</creatorcontrib><creatorcontrib>KRISTIANSON, K</creatorcontrib><creatorcontrib>LEDERBALLE-PEDERSEN, O</creatorcontrib><title>The Losartan Intervention For Endpoint Reduction (LIFE) in hypertension study: Rationale, design, and methods</title><title>American journal of hypertension</title><subject>Antihypertensive agents</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0895-7061</issn><issn>1879-1905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNo9kM1KAzEURoMoWKuPIGThokJH752fTOJOSquFAaFWcFcykxs70maGJBX69rYqrj44HM7iY-wa4Q4Bxf0rSFUkJQgcqfIWAIo8eT9hA5SlSlBBccoG_8o5uwjh8yDlQuCAbZdr4lUXtI_a8bmL5L_IxbZzfNZ5PnWm71oX-YLMrvnBo2o-m97y1vH1vicfyYUjDnFn9g98oY-S3tCYGwrthxtz7QzfUlx3JlyyM6s3ga7-dsjeZtPl5DmpXp7mk8cq6VGmMTGAKq1rlDIlkdeY2QaytJQiMwa1kSRIajAItU1r1RiLDaLVtoSisLlV2ZDd_HZ7HRq9sV67pg2r3rdb7fer9PBMCVn2DRnLXVU</recordid><startdate>19970701</startdate><enddate>19970701</enddate><creator>DAHLÖF, B</creator><creator>DEVEREUX, R</creator><creator>LINDHOLM, L. H</creator><creator>NIEMINEN, M. S</creator><creator>OMVIK, P</creator><creator>OPARIL, S</creator><creator>WEDEL, H</creator><creator>DE FAIRE, U</creator><creator>FYHRQUIST, F</creator><creator>HEDNER, T</creator><creator>IBSEN, H</creator><creator>JULIUS, S</creator><creator>KJELDSEN, S</creator><creator>KRISTIANSON, K</creator><creator>LEDERBALLE-PEDERSEN, O</creator><general>Elsevier Science</general><scope>IQODW</scope></search><sort><creationdate>19970701</creationdate><title>The Losartan Intervention For Endpoint Reduction (LIFE) in hypertension study: Rationale, design, and methods</title><author>DAHLÖF, B ; DEVEREUX, R ; LINDHOLM, L. H ; NIEMINEN, M. S ; OMVIK, P ; OPARIL, S ; WEDEL, H ; DE FAIRE, U ; FYHRQUIST, F ; HEDNER, T ; IBSEN, H ; JULIUS, S ; KJELDSEN, S ; KRISTIANSON, K ; LEDERBALLE-PEDERSEN, O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p182t-d0192bb1882e64b13fc0327863dd1ad8e6e8a0d10bf2b9cdf1c11faf7055f4f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Antihypertensive agents</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DAHLÖF, B</creatorcontrib><creatorcontrib>DEVEREUX, R</creatorcontrib><creatorcontrib>LINDHOLM, L. H</creatorcontrib><creatorcontrib>NIEMINEN, M. S</creatorcontrib><creatorcontrib>OMVIK, P</creatorcontrib><creatorcontrib>OPARIL, S</creatorcontrib><creatorcontrib>WEDEL, H</creatorcontrib><creatorcontrib>DE FAIRE, U</creatorcontrib><creatorcontrib>FYHRQUIST, F</creatorcontrib><creatorcontrib>HEDNER, T</creatorcontrib><creatorcontrib>IBSEN, H</creatorcontrib><creatorcontrib>JULIUS, S</creatorcontrib><creatorcontrib>KJELDSEN, S</creatorcontrib><creatorcontrib>KRISTIANSON, K</creatorcontrib><creatorcontrib>LEDERBALLE-PEDERSEN, O</creatorcontrib><collection>Pascal-Francis</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DAHLÖF, B</au><au>DEVEREUX, R</au><au>LINDHOLM, L. H</au><au>NIEMINEN, M. S</au><au>OMVIK, P</au><au>OPARIL, S</au><au>WEDEL, H</au><au>DE FAIRE, U</au><au>FYHRQUIST, F</au><au>HEDNER, T</au><au>IBSEN, H</au><au>JULIUS, S</au><au>KJELDSEN, S</au><au>KRISTIANSON, K</au><au>LEDERBALLE-PEDERSEN, O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Losartan Intervention For Endpoint Reduction (LIFE) in hypertension study: Rationale, design, and methods</atitle><jtitle>American journal of hypertension</jtitle><date>1997-07-01</date><risdate>1997</risdate><volume>10</volume><issue>7</issue><spage>705</spage><epage>713</epage><pages>705-713</pages><issn>0895-7061</issn><eissn>1879-1905</eissn><cop>New York, NY</cop><pub>Elsevier Science</pub><doi>10.1016/S0895-7061(97)00054-X</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0895-7061 |
| ispartof | American journal of hypertension, 1997-07, Vol.10 (7), p.705-713 |
| issn | 0895-7061 1879-1905 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_2187703 |
| source | Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
| subjects | Antihypertensive agents Biological and medical sciences Cardiovascular system Medical sciences Pharmacology. Drug treatments |
| title | The Losartan Intervention For Endpoint Reduction (LIFE) in hypertension study: Rationale, design, and methods |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T18%3A46%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Losartan%20Intervention%20For%20Endpoint%20Reduction%20(LIFE)%20in%20hypertension%20study:%20Rationale,%20design,%20and%20methods&rft.jtitle=American%20journal%20of%20hypertension&rft.au=DAHL%C3%96F,%20B&rft.date=1997-07-01&rft.volume=10&rft.issue=7&rft.spage=705&rft.epage=713&rft.pages=705-713&rft.issn=0895-7061&rft.eissn=1879-1905&rft_id=info:doi/10.1016/S0895-7061(97)00054-X&rft_dat=%3Cpascalfrancis%3E2187703%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |